NFKB1 and metabolic dysfunction-associated steatotic liver disease: Reduced AMPK activity is associated with chronic inflammatory conditions such as obesity, type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease (NAFLD) where low AMPK activity exacerbates NF-κB signalling, cytokine production and immune cell infiltration (108, 109).